Remdesivir Clinical Trial Pipeline

S. No	Title	Location	References
1	Multicenter, Retrospective Study of the Effects of Remdesivir in the Treatment of Severe Covid-19 Infections	France	https://clinicaltrials.gov/ct2/show/NCT04365725
2	Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants With Severe Coronavirus Disease (COVID-19)	United States	https://clinicaltrials.gov/ct2/show/NCT04292899
3	A Trial of Remdesivir in Adults With Mild and Moderate COVID-19	China	https://clinicaltrials.gov/ct2/show/NCT04252664
4	Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants With Moderate Coronavirus Disease (COVID-19) Compared to Standard of Care Treatment	United States	https://clinicaltrials.gov/ct2/show/NCT04292730
5	Expanded Access Treatment Protocol: Remdesivir (RDV; GS-5734) for the Treatment of SARS-CoV2 (CoV) Infection (COVID-19)	United States	https://clinicaltrials.gov/ct2/show/NCT04323761
6	Adaptive COVID-19 Treatment Trial 2 (ACTT-II)	United States	https://clinicaltrials.gov/ct2/show/NCT04401579
7	Adaptive COVID-19 Treatment Trial (ACTT)	United States	https://clinicaltrials.gov/ct2/show/NCT04280705
8	Treatments for COVID-19: Canadian Arm of the SOLIDARITY Trial	Canada	https://clinicaltrials.gov/ct2/show/NCT04330690
9	The Efficacy of Different Anti-viral Drugs in COVID 19 Infected Patients	Norway	https://clinicaltrials.gov/ct2/show/NCT04321616
10	Trial of Treatments for COVID-19 in Hospitalized Adults	France	https://clinicaltrials.gov/ct2/show/NCT04315948